Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of Body Composition on Immunoglobulin Disposition After Intravenous and Subcutaneous Administration

NCT05584631 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT05584631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05584631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of Body Composition on Immunoglobulin Disposition After Intravenous and Subcutaneous Administration
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Phase 1
Overall status
Recruiting
Start date
September 11, 2022
Completion date
December 1, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic inflammatory demyelinating polyneuropathy, cidp, immunoglobulin deficiency